Discovery of novel co-degradation CK1α and CDK7/9 PROTACs with p53 activation for treating acute myeloid leukemia.
Bioorg Chem
; 147: 107319, 2024 Jun.
Article
in En
| MEDLINE
| ID: mdl-38593529
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Screening Assays, Antitumor
/
Leukemia, Myeloid, Acute
/
Tumor Suppressor Protein p53
/
Cyclin-Dependent Kinases
/
Cyclin-Dependent Kinase 9
/
Casein Kinase Ialpha
/
Cell Proliferation
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Bioorg Chem
Year:
2024
Type:
Article
Affiliation country:
China